Anika Therapeutics Sees FY21 Sales Growth In Joint Preservation, Restoration Upper 20% To Low 30% Year-Over-Year Growth, For Joint Pain Mgmt. Up In Low Single Digit Range, For Other Down In Mid Single Digit Range